List of Tables
Table 1. Global FDA-cleared HSAT Device Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global FDA-cleared HSAT Device Market Value by Service Life (US$ Million), 2025 vs 2032
Table 3. Global FDA-cleared HSAT Device Market Value by Application (US$ Million), 2025 vs 2032
Table 4. Global FDA-cleared HSAT Device Market Competitive Situation by Manufacturers in 2025
Table 5. Global FDA-cleared HSAT Device Sales (K Units) of Key Manufacturers (2021–2026)
Table 6. Global FDA-cleared HSAT Device Sales Market Share by Manufacturers (2021–2026)
Table 7. Global FDA-cleared HSAT Device Revenue (US$ Million) by Manufacturers (2021–2026)
Table 8. Global FDA-cleared HSAT Device Revenue Share by Manufacturers (2021–2026)
Table 9. Global Market FDA-cleared HSAT Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 10. Global Key Players of FDA-cleared HSAT Device, Industry Ranking, 2023 vs 2024 vs 2025
Table 11. Global Key Manufacturers of FDA-cleared HSAT Device, Manufacturing Sites and Headquarters
Table 12. Global Key Manufacturers of FDA-cleared HSAT Device, Product Types and Applications
Table 13. Global Key Manufacturers of FDA-cleared HSAT Device, Date of Entry into the Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global FDA-cleared HSAT Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on FDA-cleared HSAT Device Revenue, 2025
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global FDA-cleared HSAT Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global FDA-cleared HSAT Device Sales by Region (K Units), 2021–2026
Table 19. Global FDA-cleared HSAT Device Sales Market Share by Region (2021–2026)
Table 20. Global FDA-cleared HSAT Device Sales by Region (K Units), 2027–2032
Table 21. Global FDA-cleared HSAT Device Sales Market Share by Region (2027–2032)
Table 22. Global FDA-cleared HSAT Device Revenue by Region (US$ Million), 2021–2026
Table 23. Global FDA-cleared HSAT Device Revenue Market Share by Region (2021–2026)
Table 24. Global FDA-cleared HSAT Device Revenue by Region (US$ Million), 2027–2032
Table 25. Global FDA-cleared HSAT Device Revenue Market Share by Region (2027–2032)
Table 26. North America FDA-cleared HSAT Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 27. North America FDA-cleared HSAT Device Sales by Country (K Units), 2021–2026
Table 28. North America FDA-cleared HSAT Device Sales by Country (K Units), 2027–2032
Table 29. North America FDA-cleared HSAT Device Revenue by Country (US$ Million), 2021–2026
Table 30. North America FDA-cleared HSAT Device Revenue by Country (US$ Million), 2027–2032
Table 31. Europe FDA-cleared HSAT Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 32. Europe FDA-cleared HSAT Device Sales by Country (K Units), 2021–2026
Table 33. Europe FDA-cleared HSAT Device Sales by Country (K Units), 2027–2032
Table 34. Europe FDA-cleared HSAT Device Revenue by Country (US$ Million), 2021–2026
Table 35. Europe FDA-cleared HSAT Device Revenue by Country (US$ Million), 2027–2032
Table 36. Asia Pacific FDA-cleared HSAT Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 37. Asia Pacific FDA-cleared HSAT Device Sales by Region (K Units), 2021–2026
Table 38. Asia Pacific FDA-cleared HSAT Device Sales by Region (K Units), 2027–2032
Table 39. Asia Pacific FDA-cleared HSAT Device Revenue by Region (US$ Million), 2021–2026
Table 40. Asia Pacific FDA-cleared HSAT Device Revenue by Region (US$ Million), 2027–2032
Table 41. Latin America FDA-cleared HSAT Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 42. Latin America FDA-cleared HSAT Device Sales by Country (K Units), 2021–2026
Table 43. Latin America FDA-cleared HSAT Device Sales by Country (K Units), 2027–2032
Table 44. Latin America FDA-cleared HSAT Device Revenue by Country (US$ Million), 2021–2026
Table 45. Latin America FDA-cleared HSAT Device Revenue by Country (US$ Million), 2027–2032
Table 46. Middle East and Africa FDA-cleared HSAT Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 47. Middle East and Africa FDA-cleared HSAT Device Sales by Country (K Units), 2021–2026
Table 48. Middle East and Africa FDA-cleared HSAT Device Sales by Country (K Units), 2027–2032
Table 49. Middle East and Africa FDA-cleared HSAT Device Revenue by Country (US$ Million), 2021–2026
Table 50. Middle East and Africa FDA-cleared HSAT Device Revenue by Country (US$ Million), 2027–2032
Table 51. Global FDA-cleared HSAT Device Sales (K Units) by Type (2021–2026)
Table 52. Global FDA-cleared HSAT Device Sales (K Units) by Type (2027–2032)
Table 53. Global FDA-cleared HSAT Device Sales Market Share by Type (2021–2026)
Table 54. Global FDA-cleared HSAT Device Sales Market Share by Type (2027–2032)
Table 55. Global FDA-cleared HSAT Device Revenue (US$ Million) by Type (2021–2026)
Table 56. Global FDA-cleared HSAT Device Revenue (US$ Million) by Type (2027–2032)
Table 57. Global FDA-cleared HSAT Device Revenue Market Share by Type (2021–2026)
Table 58. Global FDA-cleared HSAT Device Revenue Market Share by Type (2027–2032)
Table 59. Global FDA-cleared HSAT Device Price (US$/Unit) by Type (2021–2026)
Table 60. Global FDA-cleared HSAT Device Price (US$/Unit) by Type (2027–2032)
Table 61. Global FDA-cleared HSAT Device Sales (K Units) by Application (2021–2026)
Table 62. Global FDA-cleared HSAT Device Sales (K Units) by Application (2027–2032)
Table 63. Global FDA-cleared HSAT Device Sales Market Share by Application (2021–2026)
Table 64. Global FDA-cleared HSAT Device Sales Market Share by Application (2027–2032)
Table 65. Global FDA-cleared HSAT Device Revenue (US$ Million) by Application (2021–2026)
Table 66. Global FDA-cleared HSAT Device Revenue (US$ Million) by Application (2027–2032)
Table 67. Global FDA-cleared HSAT Device Revenue Market Share by Application (2021–2026)
Table 68. Global FDA-cleared HSAT Device Revenue Market Share by Application (2027–2032)
Table 69. Global FDA-cleared HSAT Device Price (US$/Unit) by Application (2021–2026)
Table 70. Global FDA-cleared HSAT Device Price (US$/Unit) by Application (2027–2032)
Table 71. WEINMANN Geraete Company Information
Table 72. WEINMANN Geraete Description and Business Overview
Table 73. WEINMANN Geraete FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 74. WEINMANN Geraete FDA-cleared HSAT Device Product
Table 75. WEINMANN Geraete Recent Developments/Updates
Table 76. SleepScore Labs Company Information
Table 77. SleepScore Labs Description and Business Overview
Table 78. SleepScore Labs FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 79. SleepScore Labs FDA-cleared HSAT Device Product
Table 80. SleepScore Labs Recent Developments/Updates
Table 81. Samsung Company Information
Table 82. Samsung Description and Business Overview
Table 83. Samsung FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 84. Samsung FDA-cleared HSAT Device Product
Table 85. Samsung Recent Developments/Updates
Table 86. PEGASI Company Information
Table 87. PEGASI Description and Business Overview
Table 88. PEGASI FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 89. PEGASI FDA-cleared HSAT Device Product
Table 90. PEGASI Recent Developments/Updates
Table 91. SleepImage Company Information
Table 92. SleepImage Description and Business Overview
Table 93. SleepImage FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 94. SleepImage FDA-cleared HSAT Device Product
Table 95. SleepImage Recent Developments/Updates
Table 96. VirtuOx Company Information
Table 97. VirtuOx Description and Business Overview
Table 98. VirtuOx FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 99. VirtuOx FDA-cleared HSAT Device Product
Table 100. VirtuOx Recent Developments/Updates
Table 101. Cadwell Industries Company Information
Table 102. Cadwell Industries Description and Business Overview
Table 103. Cadwell Industries FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 104. Cadwell Industries FDA-cleared HSAT Device Product
Table 105. Cadwell Industries Recent Developments/Updates
Table 106. Nox Medical Company Information
Table 107. Nox Medical Description and Business Overview
Table 108. Nox Medical FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 109. Nox Medical FDA-cleared HSAT Device Product
Table 110. Nox Medical Recent Developments/Updates
Table 111. Resmed Company Information
Table 112. Resmed Description and Business Overview
Table 113. Resmed FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 114. Resmed FDA-cleared HSAT Device Product
Table 115. Resmed Recent Developments/Updates
Table 116. Onera Health Company Information
Table 117. Onera Health Description and Business Overview
Table 118. Onera Health FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 119. Onera Health FDA-cleared HSAT Device Product
Table 120. Onera Health Recent Developments/Updates
Table 121. Kissei Comtec Company Information
Table 122. Kissei Comtec Description and Business Overview
Table 123. Kissei Comtec FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 124. Kissei Comtec FDA-cleared HSAT Device Product
Table 125. Kissei Comtec Recent Developments/Updates
Table 126. DormoTech Company Information
Table 127. DormoTech Description and Business Overview
Table 128. DormoTech FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 129. DormoTech FDA-cleared HSAT Device Product
Table 130. DormoTech Recent Developments/Updates
Table 131. Sibel Health Company Information
Table 132. Sibel Health Description and Business Overview
Table 133. Sibel Health FDA-cleared HSAT Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 134. Sibel Health FDA-cleared HSAT Device Product
Table 135. Sibel Health Recent Developments/Updates
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. FDA-cleared HSAT Device Distributors List
Table 139. FDA-cleared HSAT Device Customers List
Table 140. FDA-cleared HSAT Device Market Trends
Table 141. FDA-cleared HSAT Device Market Drivers
Table 142. FDA-cleared HSAT Device Market Challenges
Table 143. FDA-cleared HSAT Device Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 147. Authors List of This Report
List of Figures
Figure 1. Product Picture of FDA-cleared HSAT Device
Figure 2. Global FDA-cleared HSAT Device Market Value by Type (US$ Million), 2021–2032
Figure 3. Global FDA-cleared HSAT Device Market Share by Type: 2025 & 2032
Figure 4. Hardware Product Picture
Figure 5. Software Product Picture
Figure 6. Global FDA-cleared HSAT Device Market Value by Service Life (US$ Million), 2021–2032
Figure 7. Global FDA-cleared HSAT Device Market Share by Service Life: 2025 vs 2032
Figure 8. Single-use Device Product Picture
Figure 9. Reusable Device Product Picture
Figure 10. Global FDA-cleared HSAT Device Market Value by Application (US$ Million), 2021–2032
Figure 11. Global FDA-cleared HSAT Device Market Share by Application: 2025 & 2032
Figure 12. Clinical Monitoring
Figure 13. Academic Research
Figure 14. Others
Figure 15. Global FDA-cleared HSAT Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global FDA-cleared HSAT Device Market Size (US$ Million), 2021–2032
Figure 17. Global FDA-cleared HSAT Device Sales (K Units), 2021–2032
Figure 18. Global FDA-cleared HSAT Device Average Price (US$/Unit), 2021–2032
Figure 19. FDA-cleared HSAT Device Report Years Considered
Figure 20. FDA-cleared HSAT Device Sales Share by Manufacturers in 2025
Figure 21. Global FDA-cleared HSAT Device Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global FDA-cleared HSAT Device Players: Market Share by Revenue in FDA-cleared HSAT Device in 2025
Figure 23. FDA-cleared HSAT Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global FDA-cleared HSAT Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America FDA-cleared HSAT Device Sales Market Share by Country (2021–2032)
Figure 26. North America FDA-cleared HSAT Device Revenue Market Share by Country (2021–2032)
Figure 27. United States FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe FDA-cleared HSAT Device Sales Market Share by Country (2021–2032)
Figure 30. Europe FDA-cleared HSAT Device Revenue Market Share by Country (2021–2032)
Figure 31. Germany FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific FDA-cleared HSAT Device Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific FDA-cleared HSAT Device Revenue Market Share by Region (2021–2032)
Figure 38. China FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America FDA-cleared HSAT Device Sales Market Share by Country (2021–2032)
Figure 46. Latin America FDA-cleared HSAT Device Revenue Market Share by Country (2021–2032)
Figure 47. Mexico FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa FDA-cleared HSAT Device Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa FDA-cleared HSAT Device Revenue Market Share by Country (2021–2032)
Figure 53. Turkey FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE FDA-cleared HSAT Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of FDA-cleared HSAT Device by Type (2021–2032)
Figure 57. Global Revenue Market Share of FDA-cleared HSAT Device by Type (2021–2032)
Figure 58. Global FDA-cleared HSAT Device Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of FDA-cleared HSAT Device by Application (2021–2032)
Figure 60. Global Revenue Market Share of FDA-cleared HSAT Device by Application (2021–2032)
Figure 61. Global FDA-cleared HSAT Device Price (US$/Unit) by Application (2021–2032)
Figure 62. FDA-cleared HSAT Device Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
